Arcadia Biosciences Cash Flow - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$1.71 $0.05 (2.84%) RKDA stock closing price Oct 20, 2016 (Closing)

The financial analysis of RKDA requires an investor to check the cash flows for Arcadia Biosciences. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Arcadia Biosciences profits one has to check the income statement and for Arcadia Biosciences debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in Arcadia Biosciences stock analysis. Arcadia Biosciences had a negative net income cash flow of $-9.74M for the latest quarter. This report is very useful in measuring the short term viability of a company. Arcadia Biosciences has a positive cash and cash equivalents change of $3.38M. View details of Arcadia Biosciences cash flows for latest & last 40 quarters.

show more
Get Cash flow for another ticker
Fiscal year is Jan - Dec. 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Arcadia Biosciences Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow0.28M0.14M0.37M0.21M0.14M0.07M0.35M0.27M0.18M0.09M
Net Increase (Decrease) in Assets Liabilities0.11M-0.07M-0.05M0.52M0.81M1.2M-1.33M-0.08M-0.85M0.43M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.49M0.26M2.52M2.2M1.93M1.92M4.53M4.03M1.53M0.82M
Arcadia Biosciences Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.19M-0.13M-0.14M-0.08M-0.02M-0.01M-0.14M-0.03M--
Acquisition Disposition of Subsidiaires-------1.45M-1.45M-0.95M-0.7M
Increase (Decrease) in Investments12.2M10.46M-46.21M-11.29M------
Other Cash Inflow (Outflow) from Investment Activities----------
Arcadia Biosciences Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares0.27M0.13M68.58M68.39M68.25M-32.86M32.85M32.84M0.88M
Issuance (Repayment) of Debt Securities--10.2M8.87M8.87M-1.45M-1.15M-0.89M-0.63M-0.37M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.04M-0.04M-9.92M-8.34M-7.09M-1.23M-1.59M-0.01M--
Arcadia Biosciences Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Arcadia Biosciences Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M-------
Cash & Equivalents at Year End27.36M29.54M23.97M62.96M80M11.27M16.57M21.17M25.67M0.51M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Arcadia Biosciences stock price history and Arcadia Biosciences stock comparison chart inevitably reflect its cash flow situation.
  • Net Change in Cash and Cash Equivalents: Arcadia Biosciences cash reduced QoQ to $-9.74M, meaning the company is unable to meet its expenditure and grow cash which will also eventually reflect in the Arcadia Biosciences stock price movement.
  • Arcadia Biosciences decreased its cash from operating activities to $3.99M in 2016-Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a positive value of $12M for RKDA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between Arcadia Biosciences and its owners and creditors and was $0.22M for 2016-Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin